INDICATIONS AND USAGE

AVAPRO® (irbesartan) is indicated for the treatment of hypertension, to lower blood pressure. Full Indication
AVALIDE® (irbesartan and hydrochlorothiazide) tablets are indicated for the treatment of hypertension. Full Indication

For US Healthcare Professionals Only

AVAPRO: PROVEN 24-HOUR EFFICACY

AVAPRO is a once-a-day oral angiotensin II receptor blocker (ARB) with demonstrated efficacy in treating mild-to-moderate hypertension.1

When it comes to helping your patients with mild-to-moderate hypertension reach their goals, AVAPRO is a proven therapeutic option that provides effective 24-hour blood pressure control.1

AVALIDE: FOR YOUR PATIENTS WHO NEED ADDED EFFICACY

AVALIDE is a once-a-day combination of irbesartan, an angiotensin II receptor blocker (ARB) and hydrochlorothiazide (HCTZ), indicated for hypertension in patients not adequately controlled with monotherapy.2,3

When it comes to helping your mild-to-moderate hypertensive patients who need added efficacy, AVALIDE is a proven therapeutic option that provides effective, 24-hour blood pressure control.2,3

AVAILABLE AUTHORIZED GENERIC

Learn more about the Irbesartan-Authorized Generics

References

1. Fogari R, Ambrosoli S, Corradi L, et al. 24-hour blood pressure control by once-daily administration of irbesartan assessed by ambulatory blood pressure monitoring. J Hypertens. 1997;15:1511-1518.

2. Howe P, Phillips P, Saini R, Kassler-Taub K. The antihypertensive efficacy of the combinations of irbesartan and hydrochlorothiazide assessed by 24-hour ambulatory blood pressure monitoring. Clin Exp Hypertens. 1999;21:1373-1396.

3. Neutel JM, Saunders E, Bakris GL, et al; INCLUSIVE Investigators. The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial. J Clin Hypertens. 2005;7:578-586.